logo

Regeneron Pharmaceuticals (REGN)



Trade REGN now with
  Date
  Headline
9/13/2018 7:02:26 AM Regeneron: FDA To Review EYLEA Injection For Treatment Of Diabetic Retinopathy
9/12/2018 8:04:28 AM Sanofi: FDA To Review SBLA For Praluent Injection As Potential Treatment To Reduce Major Adverse Cardiovascular Events
9/12/2018 1:00:30 AM Regeneron, Sanofi: FDA Accepts SBLA For Praluent Injection
8/17/2018 7:01:49 AM Regeneron Pharma: FDA Approves EYLEA Injection SBLA In Wet Age-related Macular Degeneration
8/16/2018 7:02:28 AM Regeneron, Teva Unveil Positive Topline Phase 3 Fasinumab Results In Patients With Chronic Pain From OA Of Knee/Hip
8/13/2018 7:03:26 AM Regeneron Provides Regulatory Update On EYLEA Injection; Expects To Get A Final FDA Action Within About Two Months
8/6/2018 6:32:25 AM Bluebird Bio, Regeneron Partner To Apply Technology Platforms To Develop Novel Cell Therapies For Cancer